Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Asarinin
2. Epi-sesamin
3. Episesamin
4. Sesamin, (1r-(1alpha,3aalpha,4alpha,6aalpha))-isomer
5. Sesamin, (1r-(1alpha,3aalpha,4beta,6aalpha))-isomer
1. 607-80-7
2. Fagarol
3. Sezamin
4. (+)-sesamin
5. Asarinin
6. D-(+)-sesamin
7. D-sesamin
8. Episesamin
9. (+/-)-sesamin
10. Sesamin Dl-form [mi]
11. Sesamin, (+/-)-
12. Pseudocubebin
13. (+)-segamin
14. Chebi:66470
15. Fy3s29jvc9
16. S7946o4p76
17. 81602-22-4
18. Pseudo Cubebin
19. 1h,3h-furo(3,4-c)furan, Tetrahydro-1,4-bis(3,4-(methylenedioxy)phenyl)-, (1s,3ar,4s,6ar)-
20. 1,3-benzodioxole, 5,5'-((1r,3as,4r,6as)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, Rel-
21. 5-[(3s,3ar,6s,6ar)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-1,3-benzodioxole
22. L-sesamin
23. Ai3-00811
24. 5-[(3s,3ar,6s,6ar)-6-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodioxole
25. Smr000445559
26. Sr-01000777562
27. Nsc 36403
28. Unii-fy3s29jvc9
29. Fsesamin
30. Nsc-36403
31. Unii-s7946o4p76
32. Sesamin (fagarol)
33. Sesamin - Fagarol
34. Sesamin,(s)
35. Rel-(7s,7's8r,8'r)-sesamin
36. Mfcd00216134
37. Sesamin [mi]
38. Sesamin [who-dd]
39. Sesamin, Analytical Standard
40. Schembl94517
41. Sesamin D-form [mi]
42. Mls000728578
43. Mls002473316
44. Chembl252915
45. Sesamin, >=95%, Crystalline
46. Sesamin, >=98% (hplc)
47. Acon0_000323
48. Acon1_002421
49. Gtpl11372
50. Dtxsid301030528
51. Hms2232f11
52. Hy-n0121
53. Zinc1668768
54. Bdbm50542904
55. S2392
56. Akos022168195
57. Ccg-268081
58. Dioxol-5-yl)hexahydrofuro[3,4-c]furan
59. Ncgc00169864-01
60. Ncgc00169864-02
61. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3aalpha,4alpha,6aalpha)-
62. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3aalpha,4alpha,6aalpha)-(+/-)-
63. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1s-(1alpha,3a Alpha,4alpha,6a Alpha))-
64. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diyl)bis-, (1s,3ar,4s,6ar)-
65. As-13527
66. Rel-(7s,7's,8r,8'r)-sesamin
67. Cs-0007831
68. (1s,3ar,4s,6ar)-1,4-di(benzo[d][1,3]
69. 607s807
70. A832882
71. Q-100697
72. Q3511416
73. Sr-01000777562-3
74. Sr-01000777562-4
75. (1s,3ar,4s,6ar)-1,4-bis(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan
76. (1s,3ar,4s,6ar)-1,4-di(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan
77. 5,5'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(1,3-benzodioxol)
78. 5,5'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(1,3-benzodioxole)
79. 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-1,3-benzodioxole
80. Tetrahydro-1,4-bis(3,4-(methylenedioxy)phenyl)-1h,3h-furo(3,4-c)furan
81. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1.alpha.,3a.alpha.,4.alpha.,6a.alpha.)-
82. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1.alpha.,3a.alpha.,4.alpha.,6a.alpha.)-(+/-)-
83. 1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1s-(1.alpha.,3a .alpha.,4.alpha.,6a .alpha.))-
Molecular Weight | 354.4 g/mol |
---|---|
Molecular Formula | C20H18O6 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 55.4 |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 482 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticholesteremic Agents
Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?